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Edited by Gianni CesareniAbstract Taste-modifying proteins are a natural alternative to
artiﬁcial sweeteners and ﬂavor enhancers and have been used in
some cultures for centuries. The taste-modifying protein, miracu-
lin, has the unusual property of being able to modify a sour taste
into a sweet taste. Here, we report the use of a plant expression
system for the production of miraculin. A synthetic gene encod-
ing miraculin was placed under the control of constitutive pro-
moters and transferred to lettuce. Expression of this gene in
transgenic lettuce resulted in the accumulation of signiﬁcant
amounts of miraculin protein in the leaves. The miraculin ex-
pressed in transgenic lettuce possessed sweetness-inducing activ-
ity. These results demonstrate that the production of miraculin in
edible plants can be a good alternative strategy to enhance the
availability of this protein.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Bulk sweeteners and ﬂavorsome ingredients, such as sugars,
are essential foods that are important in food processing and
contribute many beneﬁts to foods. In recent years, the demand
for ‘‘low-calorie’’ sweeteners has increased [1]. Artiﬁcial sweet-
eners like saccharin, aspartame, cyclamate, and acesulfame K
are used worldwide as low-calorie sweeteners by patients with
diseases linked to the consumption of sugar, such as diabetes,
hyperlipemia, caries, and obesity; however, these substances
can cause side eﬀects, including psychological problems, men-
tal disorders, bladder cancer, heart failure, and brain tumors
[2]. Therefore, there is an intense, ongoing search for alterna-
tive sweeteners. Generally, high-molecular-weight substances
do not stimulate taste cells and therefore have no taste. How-
ever, higher-molecular-mass sweet and taste-modifying pro-
teins have been discovered that interact with the taste
receptors in a potent and speciﬁc manner [3].Abbreviations: BAP, 6-benzylaminopurine; CaMV, cauliﬂower mosaic
virus; NAA, 1-naphthaleneacetic acid; PAGE, polyacrylamide gel
electrophoresis; PCR, polymerase chain reaction; SDS, sodium dode-
cyl sulfate
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doi:10.1016/j.febslet.2005.12.080Sweet and taste-modifying proteins have traditionally been
used by West Africans to improve ﬂavor and suppress bitter-
ness in food and drink. For example, they are used to improve
the ﬂavor of maize dishes, such as agidi, and beverages, such as
palm wine or tea. In modern times, these proteins have been
used in the food-processing industry as sweetening agents, ﬂa-
vor enhancers, and animal fodder supplements. These proteins
can act at extremely low concentrations, and because of this
low eﬀective dose, they are eﬀectively non-cariogenic and
acceptable for diabetics in ﬂavor and sweetening formulations.
With the commercialization of thaumatin [4], there has been an
increasing interest in these compounds. There are seven known
sweet or taste-modifying proteins: thaumatin, monellin [5],
mabinlin [6], pentadin [7], brazzein [8], curculin [9], and mira-
culin [10]. The genes for these proteins have been cloned and
sequenced, and many have been expressed in foreign hosts
[1,3,4,11].
Richadella dulciﬁca, a shrub native to tropical West Africa,
produces red berries that have the unusual ability to modify
a sour taste into a sweet taste. For example, lemons taste like
oranges when they are eaten after these berries have been
chewed. Owing to this unique property, the berry has been
called the miracle fruit. The active ingredient in the berry, mir-
aculin, is a taste-modifying protein that causes citric acid,
ascorbic acid, and acetic acid, which are normally sour, to be
perceived as sweet after the berry has been held in the mouth.
Miraculin was ﬁrst isolated by Kurihara and Beidler [12].
The complete amino acid sequence of miraculin has been
determined [13], and the cDNA corresponding to miraculin
has been cloned and sequenced [14]. Miraculin by itself does
not elicit a sweet response. Like curculin, however, it can mod-
ify a sour taste into a sweet taste. Kurihara and Beidler [12]
therefore termed the protein a taste-modifying protein. The
maximum sweetness after exposure to 0.4 lM miraculin in-
duced by 0.02 M citric acid was estimated to be around
400000 times that of sucrose on a molar basis [10,11,15,16].
Therefore, to supply the same sweetening eﬀect as sucrose,
only minute amounts of miraculin are required. This results
in an almost negligible addition to the calorie count. There-
fore, miraculin could be used as a natural low-calorie sweet-
ener by individuals suﬀering from diseases linked to the
consumption of sugars, including obesity, diabetes, and hyper-
lipemia, and to control the palatability of foods.
The taste-modifying protein, miraculin, is obviously an
attractive alternative to some of the more traditional sweeten-
ers, such as sucrose. However, the commercial feasibility of
miraculin is very low because the natural source of this protein
is a tropical plant that is diﬃcult to cultivate outside of itsblished by Elsevier B.V. All rights reserved.
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particular product, extraction from the natural plant may
not be able to keep up with demand. Therefore, as an alterna-
tive to the production of miraculin from its natural source, at-
tempts have been made to produce recombinant miraculin in
Escherichia coli [17], yeast [16], and transgenic tobacco [16].
Although miraculin has been expressed in these organisms, re-
combinant miraculin lacks the sweetness-inducing activity.
Genetic engineering of plants may oﬀer a solution to this
problem. The development of genetic transformation technol-
ogy for plants has enabled the expression of foreign genes in
diﬀerent plant species, allowing the use of plants as bioreactors
to produce recombinant proteins. Transgenic plants are being
used to produce desired recombinant proteins, such as vac-
cines, antibodies, mammalian hormones, biopharmaceuticals,
and food additives [18–22].
In this study, we attempted to express the taste-modifying
protein, miraculin, in lettuce as a potential alternative sweet-
ener. Lettuce is an agricultural crop that is widely grown
worldwide. A synthetic gene encoding miraculin was assem-
bled and inserted into plant expression vectors. Recombinant
miraculin was expressed in transgenic lettuce and showed
strong sweetness-inducing activity. To our knowledge, this is
the ﬁrst report on the production of the biologically active
form of miraculin in a foreign host.2. Materials and methods
2.1. Synthesis of miraculin cDNA and construction of plasmids for its
expression
Total RNA was isolated from the pulp of R. dulciﬁca berries using an
RNeasy Plant Mini Kit (Qiagen). cDNA was synthesized from a 1-lg
total RNA sample following the protocol of the RT-PCR High kit
(Toyobo). Based on the published DNA sequence of miraculin [14]
(Accession No. D38598), a pair of speciﬁc primers (forward primer:
5 0-TTTTCTAGAATGAAGGAATTAACAATGCT-30, and reverse
primer: 5 0-TTTGAGCTCTTAGAAGTATACGGTTTTGT-3 0) was
designed and used to amplify the coding region of miraculin. The for-
ward primer contained the recognition sequence for XbaI, and the
reverse primer contained the recognition sequence for SacI. The ampli-
ﬁcation reaction consisted of 95 C for 5 min, 40 cycles of ampliﬁcation
(95 C for 1 min, 57 C for 1 min, and 72 C for 2 min), and a ﬁnal
extension at 72 C for 10 min. The resulting polymerase chain reaction
(PCR) fragments were puriﬁed and subcloned into the XbaI/ SacI sites
of the plasmid pUC19. The sequences of this clone were conﬁrmed by
DNA sequencing. The plasmid pUC19 was digested withXbaI and SacI
to clone the miraculin-encoding 660-bp DNA fragment into the XbaI/
SacI sites of the plant transformation vectors pBI121 (Clontech) and
pBE2113-GUS [23] after removing the GUS-coding region. The result-
ing plasmids, named 35S-MIR and El2-MIR, contained the miraculin
coding region. 35S-MIR and El2-MIR were transferred to Agrobacte-
rium tumefaciensGV2260 [24] using the method of Shen and Forde [25].
2.2. Transformation of lettuce plants
Lettuce seeds (Lactuca sativa cv Kaiser) were surface sterilized and
germinated on Murashige and Skoog (MS) medium [26] with 2% (w/
v) sucrose and 0.2% (w/v) Gelrite under a 16-h light/8-h dark photope-
riod at 25 C. The lettuce plants were transformed by infection with A.
tumefaciens GV2260 harboring the binary vectors 35S-MIR and El2-
MIR. Agrobacterium strains were grown in 2 ml of LB medium con-
taining 100 mg/l kanamycin at 28 C for 24 h and then diluted 1:40
(v/v) in liquid MS medium containing 0.1 mM acetosyringone (Sig-
ma–Aldrich) and 0.01 mM 2-mercaptoethanol. Excised cotyledons
from 5-day-old seedlings were inoculated by immersion for 5 min in
the diluted bacterial suspension and transferred to a solid co-cultiva-
tion medium supplemented with 1 mg/l 6-benzylaminopurine (BAP)
and 0.1 mg/l 1-naphthaleneacetic acid (NAA). After 3 days ofco-cultivation, the explants were transferred to solid MS medium con-
taining 0.1 mg/l BAP, 0.1 mg /l NAA, 100 mg/l kanamycin, and
375 mg/l Augmentin (GlaxoSmithKline) for the selection of trans-
formed shoots. About 4 weeks after explant inoculation, the levels of
kanamycin, BAP, and NAA were reduced to 50, 0.01, and 0.05 mg/l,
respectively. Approximately 2- to 3-cm-long shoots were excised and
transferred to solid MS medium containing 50 mg/l kanamycin for
rooting. After incubation in the conditioned medium, transformants
were selected. The transgenic plants were kept at 25 C under a 16-h
light/8-h dark photoperiod with ﬂuorescent light at an intensity of
60 lmol m2 s1.
2.3. Southern hybridization analysis
Genomic DNA was extracted from 0.5 g of fresh young leaves using
the CTAB extraction method of Rogers and Bendich [27]. For South-
ern blot analysis, 10 lg of genomic DNA were digested with XbaI, elec-
trophoresed on a 1% agarose gel at 50 V for 4 h, and transferred to a
Hybond-N+ (Amersham Biosciences) nylon membrane under alkaline
conditions. The membrane was hybridized overnight at 60 C with a
660-bp 32P-labeled miraculin gene fragment ampliﬁed by PCR using
the two primers described above. The membrane was given a ﬁnal
wash in 2 · SSC containing 0.1% sodium dodecyl sulfate (SDS) at
60 C for 15 min. The hybridization signals were detected using
BAS-5000 image analyzer (Fuji Photo Film, Japan).
2.4. Northern hybridization analysis
Total RNA was isolated from leaf tissue of transgenic and wild-type
lettuce plants using an RNeasy Plant Mini Kit (Qiagen). Fifteen micro-
grams of total RNA were size-fractionated on an agarose gel contain-
ing 1% formaldehyde and transferred to a Hybond-N+ (Amersham
Biosciences) nylon membrane. Northern blot hybridizations were car-
ried out under the same conditions as described for Southern blot
hybridization.
2.5. Preparation of anti-miraculin antibody
Anti-miraculin antibody was prepared as follows: recombinant pro-
tein containing amino acids 1–191 of mature miraculin was produced
in E. coli using pQE30 (Qiagen) and used to raise antiserum in rabbits
with the assistance of the Scrum Inc. (Tokyo, Japan). Rabbit anti-mir-
aculin antibody was puriﬁed by fractionation with ammonium sulfate
(40% saturation) followed by immunoaﬃnity chromatography on a
column of Sepharose 4 Fast Flow (Amersham Biosciences) which
was coupled with the N-terminal 89-residue polypeptide of mature mir-
aculin (residues 1–89 of miraculin) produced in E. coli using pGEX-
4T-1 (Amersham Biosciences) following the cyanogen bromide proce-
dure [28].
2.6. Puriﬁcation of miraculin from miracle fruit and transgenic lettuce
Native miraculin was puriﬁed from the pulp of R. dulciﬁca according
to a described method [10]. Recombinant miraculin was puriﬁed from
the transgenic lettuce plant lines expressing the most miraculin (35S-
MIR 29B and 16B and El2-MIR 13A and 38A). Fully expanded young
leaves (100 g fresh weight) were collected and ground in liquid nitrogen
to a ﬁne powder. The powder was resuspended in 200 ml of extraction
buﬀer, consisting of 50 mM Tris–HCl (pH 8.0), 500 mM NaCl, 2 mM
EDTA, and 4% polyvinylpolypyrrolidone (PVPP). The leaf extract was
centrifuged at 15000 rpm for 20 min at 4 C and the resultant superna-
tant was dialyzed against 0.02 M sodium phosphate buﬀer (pH 7.2).
The dialyzed solution was applied to a column (2.0 · 35 cm, bed vol-
ume: 94 ml) of CM-Sepharose Fast Flow (Amersham Biosciences),
which was equilibrated with 0.02 M sodium phosphate buﬀer (pH
7.2) at a ﬂow rate of 25 ml/h. It was eluted with a linear gradient start-
ing with 200 ml of the 0.02 M sodium phosphate buﬀer (pH 7.2) in a
mixing ﬂask and 200 ml of the same buﬀer solution containing 1.0 M
of NaCl. The fractions containing miraculin were collected and dia-
lyzed against 0.02 M sodium phosphate buﬀer (pH 7.2) containing
0.5 M NaCl. The dialyzed solution was applied to a Con A Sepharose
4B (Amersham Biosciences) column (1.6 · 10 cm, bed volume: 14 ml)
equilibrated with 0.02 M sodium phosphate buﬀer (pH 7.2) containing
0.5 M NaCl at a ﬂow rate of 30 ml/h. The column was washed with the
starting buﬀer. It was then eluted with a linear gradient starting with
50 ml of the starting buﬀer in a mixing ﬂask and 50 ml of the same buf-
fer solution containing 0.15 M of methyl-a-D-glucoside (Tokyo
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trated. The concentrated solution was applied to a Sephacryl S-200 HR
column (2.6 · 110 cm, Amersham Biosciences) equilibrated with
0.05 M phosphate buﬀer solution (pH 6.4) containing 0.15 M NaCl
at a ﬂow rate of 60 ml/h. The active fractions were collected and used
as puriﬁed recombinant miraculin.
2.7. Western blot analysis and enzyme-linked immunosorbent assay
(ELISA)
The expression levels of the lettuce plants expressing miraculin were
determined using immunological measurements. Soluble protein was
extracted from frozen leaf samples. Fully expanded young leaves were
collected and ground in liquid nitrogen to a ﬁne powder. The powder
(0.2 g) was resuspended in 400 ll of extraction buﬀer consisting of
50 mM Tris–HCl (pH 8.0), 0.5 M NaCl, 2 mM EDTA, and 4% PVPP.
The leaf extract was centrifuged at 15000 rpm for 20 min at 4 C, and
the resulting supernatant was used for Western blot analysis and ELI-
SA. The extracted proteins (25 lg per lane) were separated by SDS–
polyacrylamide gel electrophoresis (PAGE) and transferred onto
Hybond-P membrane (Amersham Biosciences). After blocking with
3% gelatin, the blots were reacted with aﬃnity-puriﬁed anti-miraculin
antibody at room temperature for 1 h. The immunoreactive proteins
were detected using a Western blotting detection kit (Bio-Rad). In
addition, the miraculin concentration of the transgenic lettuce was
measured using an ELISA using anti-miraculin IgG and peroxidase-
conjugated anti-miraculin IgG as described [29]. Peroxidase-conju-
gated anti-miraculin IgG was prepared using a Peroxidase Labelling
Kit-SH (Dojindo, Japan). A dilution series of puriﬁed native miraculin
and a non-transgenic lettuce sample were included in the assay for ref-
erence. The protein concentration of extracts was determined using a
BCA protein assay kit (Pierce).
2.8. Analysis of dimerization and N-glycosylation of recombinant
miraculin expressed in transgenic lettuce
Dimerization of the recombinant miraculin expressed in transgenic
lettuce was conﬁrmed using non-reducing and reducing SDS–PAGE.
Extracts (25 lg per lane) from transgenic lettuce plants were separated
by SDS–PAGE under non-reducing and reducing conditions and ana-
lyzed by Western blotting as described above. The N-glycosylation of
recombinant miraculin was analyzed using Western blot after treat-
ment with N-glycosidase A (Roche). The total soluble proteins
(50 lg) extracted from transgenic lettuce were prepared in 0.01 M so-
dium acetate buﬀer (pH 5.1) and boiled for 5 min, and then 4 mU
N-glycosidase A (Roche) were added. Enzyme digests were conducted
at 37 C for 24 h, and aliquots of protein were subjected to SDS–
PAGE in the presence of dithiothreitol and then to Western blot
analysis. Puriﬁed native miraculin (0.5 lg) was treated with 2 mU
N-glycosidase A under the same conditions and included in the analy-
sis for reference.
2.9. Measurements of taste-modifying activity
The taste-modifying activity of miraculin was assayed using six sub-
jects, as described previously [15]. Prior to evaluation, subjects tasted
repeatedly a series of standard sucrose solutions (0.1–1.0 M). Then,
they either chewed one or two grams of lettuce leaf for 3 min or held
5 ml of 0.4 lM puriﬁed miraculin solution in the mouth for 3 min
and spat out. The mouth was rinsed with water and then 0.02 M citric
acid was tasted. The sweetness induced by 0.02 M citric acid was eval-
uated by comparing its sweetness to that of a series of standard sucrose
solutions. The subjects were asked to choose which of ten sucrose solu-
tions best approximated the intensity of sweetness induced by the acid.
At least 3 h was interposed between each test.3. Results
3.1. Transforming lettuce plants with the miraculin gene
Miraculin accumulates speciﬁcally in the pulp of the miracle
fruit [14]. To determine if miraculin could be produced in other
plant tissues, we constructed chimeric genes using the miraculin
gene and two diﬀerent promoters (Fig. 1A). Lettuce plants
were transformed by infection with A. tumefaciens strainGV2260 [24] harbouring the binary vectors 35S-MIR and
El2-MIR. The presence of the miraculin gene in these plants
was conﬁrmed by Southern blot analysis (Fig. 1B). Genomic
DNA from 40 transformed plants was digested with XbaI
endonuclease, which cuts the T-DNA in plasmids 35S-MIR
and El2-MIR only once outside the miraculin gene, so the
number of bands, in most cases, should be equal to the number
of transgenes. The hybridization of restricted genomic DNA
from the selected transformed lines with radiolabeled probe
for the miraculin gene revealed that the clones represented
independent transformation events, and the number of trans-
gene copies varied from one to several in diﬀerent transformed
lines. Thirty-six independent transgenic lettuce plants were
obtained (Fig. 1B).3.2. Accumulation of miraculin mRNA in transgenic lettuce
To determine whether transgenic lettuce plants expressed the
miraculin mRNA, Northern blot analysis was carried out
using total RNA isolated from 19 randomly selected trans-
formed lines. Northern blot analysis showed the presence of
miraculin transcripts in 13 transformed lines, whereas no tran-
scripts were detected in untransformed plants. The transfor-
mants showed variation in expression. We found no
correlation between the number of copies of the miraculin gene
in a lettuce genome and its level of expression, although the le-
vel of miraculin gene expression was higher in single-copy
transformants than in multi-copy transformants. These results
indicate that miraculin mRNA was successfully expressed in
lettuce leaf tissue (Fig. 2A).
3.3. Expression of the miraculin protein in transgenic lettuce
To assay for the production of miraculin, lettuce leaf protein
was isolated and analyzed using Western blotting (Fig. 2B). As
expected, miraculin was not detected in leaves harvested from
untransformed control lettuce. In contrast, miraculin was de-
tected in three transgenic lettuce plants bearing an El2-miracu-
lin gene and in ﬁve transgenic lettuce plants bearing a 35S-
miraculin gene (Fig. 2B). The expression levels in the diﬀerent
plant lines varied markedly. Unexpectedly, a comparison of
the expression level in El2-35S-X and 35S promoter plants
showed that the expression was not higher with the El2-35S-
X promoter. The miraculin protein in lettuce plants was very
similar in size to the native miraculin extracted from the pulp
of R. dulciﬁca berries.
3.4. Analysis of dimerization and N-glycosylation of
recombinant miraculin expressed in transgenic lettuce
Miraculin exists naturally as a disulﬁde-linked dimer and is a
basic glycoprotein. The molecular weight of the miraculin di-
mer was 43 kDa on SDS–PAGE [17]. Since the molecular
weight of the recombinant miraculin expressed in lettuce was
about 45 kDa on non-reduced SDS–PAGE (Fig. 2B), it is pos-
sible that the recombinant miraculin forms a disulﬁde-linked
dimer and is glycosylated.
To conﬁrm the dimerization of the miraculin subunits ex-
pressed in transgenic lettuce, soluble protein extracts from
the transgenic lettuce plants were analyzed by Western blot-
ting, and the results are shown in Fig. 3A. The molecular
weights of the miraculin under non-reducing and reducing con-
ditions were about 45 and 28 kDa, respectively. These results
suggest that the miraculin expressed in transgenic lettuce is a
Fig. 1. Map of the T-DNA region of binary vectors 35S-MIR and El2-MIR (A) and Southern hybridization analysis of lettuce transformants (B).
RB, right border of T-DNA; LB, left border of T-DNA; Pnos, nopaline synthase gene promoter; NPTII, neomycin phosphotransferase gene; Tnos,
nopaline synthase gene terminator; P35S, CaMV 35S promoter; El2-35S-X, promoter cassette containing a translational enhancer; miraculin,
miraculin gene. The genomic DNA from 40 transgenic lettuce plants (1B-29B) and a wild-type lettuce plant (Wt) were used for Southern blot
analysis.
Fig. 2. Expression of miraculin RNA and protein in T0 transgenic lettuce plants. (A) Accumulation of miraculin RNA in transgenic lettuce plants.
Lanes: Wt, untransformed lettuce plant; 13A-10B, transgenic lettuce plants. Bottom: ribosomal RNA after ethidium bromide staining is shown for
equal loading. (B) Detection of miraculin protein in transgenic lettuce plants. Lanes: Wt, untransformed lettuce plant; M, extract from miracle fruit
as positive control; 13A-25C, transgenic lettuce plants derived from El2-MIR construct; 5A-10B, transgenic lettuce plants derived from 35S-MIR
construct. The size of the protein standard is shown in kDa on the left.
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Fig. 3. Analysis of the post-translational modiﬁcation of recombinant
miraculin expressed in transgenic lettuce. (A) Analysis of the dimer-
ization of recombinant miraculin expressed in transgenic lettuce. SDS–
PAGE was performed under non-reducing and reducing conditions.
Lanes: 13A and 38A, transgenic lettuce lines derived from El2-MIR
construct; 29B and 16B, transgenic lettuce lines derived from 35S-MIR
construct. (B) Analysis of the N-glycosylation of recombinant mira-
culin in lettuce. SDS–PAGE was performed under reducing condi-
tions. Lanes: MIR, puriﬁed miraculin from miracle fruit; 38A,
transgenic lettuce line derived from El2-MIR construct; 29B, trans-
genic lettuce line derived from 35S-MIR construct. The size of the
protein standard is shown in kDa on the left.
able 1
oncentration of miraculin in transgenic lettuce plants
Transformants
El2-MIR 35S-MIR
13A 38A 29B 16B
g miraculin/g fresh weighta 33.7 42.3 43.5 39.8
g total soluble protein/g fresh weight 4.7 4.5 4.3 5.1
g miraculin/mg total soluble protein 7.2 9.4 10.1 7.8
he miraculin concentration was determined for a protein extract
btained from transgenic lettuce.
he miraculin content was measured using an enzyme-linked immu-
osorbent assay, as described in Section 2. The protein concentration
as determined as described in Section 2.
Fig. 4. Non-reducing (lanes 1–5) and reducing SDS–PAGE (lane 8) of
products from the multi-step puriﬁcation for the isolation of miraculin
from transgenic lettuce. Lanes: 1, puriﬁed native miraculin from
miracle fruit; 2, crude extract from transgenic lettuce; 3, miraculin peak
from cation-exchange chromatography; 4, miraculin peak from aﬃnity
chromatography; 5, puriﬁed miraculin (dimer) from gel ﬁltration
chromatography; 6 and 7, standard marker proteins; 8, puriﬁed
miraculin (monomer). The size of the protein standard is shown in kDa
on the left.
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interchain disulﬁde linkages between the miraculin subunits.
Since miraculin contains two N-glycosylation sites [13], we
tested whether the miraculin in lettuce is glycosylated. Soluble
protein extracts from the transgenic lettuce plants were treated
with peptide N-glycosidase A (PNGase A, Roche), a glycoami-
dase that liberates N-linked oligosaccharides from glycopep-
tides and glycoproteins [30]. As shown in Fig. 3B, after
N-glycosidase A treatment, smaller bands with a molecular
mass of approximately 23 kDa were detected in lettuce, as in
native miraculin. This indicates that the recombinant miracu-
lin in transgenic lettuce is an N-glycosylated protein.
3.5. Quantiﬁcation of the recombinant miraculin in transgenic
lettuce
The miraculin content in crude extracts of transgenic lettuce
plants was measured using an ELISA with aﬃnity-puriﬁed
anti-miraculin IgG and peroxidase-conjugated anti-miraculin
IgG. The results for the two highest-producing transgenic let-
tuce plants for each line derived from the two constructs are
shown in Table 1. The concentrations of miraculin from the
two El2-MIR construct plants and two 35S-MIR construct
plants were 33.7, 42.3, 43.5, and 39.8 lg per gram fresh weight,









wconstituted approximately 1% of the total soluble protein ex-
tracted from the transgenic lettuce.
3.6. Puriﬁcation of native and recombinant miraculin
To test whether the puriﬁed miraculin retains its intrinsic
sweetness-inducing activity, native and recombinant miraculin
were puriﬁed. Native miraculin was puriﬁed from the pulp of
R. dulciﬁca according to a described method [10], using miracle
fruit pulp free from skin and seeds. Approximately 4.3 mg of
pure native miraculin were obtained from 15 g of fresh miracle
fruit. The puriﬁed miraculin gave a single band with a molec-
ular weight of 45 kDa on non-reducing SDS–PAGE (Fig. 4).
The recombinant miraculin was puriﬁed from the highest mir-
aculin-expressing transgenic lettuce plant lines, as described in
Section 2. The fractions generated during a representative puri-
ﬁcation step were subject to Western blot analyses using anti-
miraculin antibody. The fractions were also analyzed using
SDS–PAGE, and the results are shown in Fig. 4. The puriﬁed
Table 2
Sweetness intensity induced by native and recombinant miraculin
Source material Concentration of miraculin in taste sample (lg) Induced sweetnessa (SEV) (M)
Miracle fruit (one fresh fruit) 120.0 0.31 ± 0.01
Lettuce leaf tissue (1 g fresh weight) 43.5 0.19 ± 0.01
Lettuce leaf tissue (2 g fresh weight) 87.0 0.30 ± 0.01
Puriﬁed native miraculin 90.0 0.32 ± 0.02
Puriﬁed recombinant miraculin 90.0 0.31 ± 0.01
The miraculin concentration of the source material was measured using an enzyme-linked immunosorbent assay, as described in the materials and
methods.
aThe sucrose equivalence value (SEV) corresponds to the sweetness intensity induced by 0.02 M citric acid evaluated by comparing its sweetness to
that of a series of standard sucrose solutions (0.1–1.0 M). Data represent the mean of six subjects ± S.E.
H.-J. Sun et al. / FEBS Letters 580 (2006) 620–626 625miraculin gave multiple broadbands on SDS–PAGE, and the
molecular weights of the puriﬁed miraculin under non-reduc-
ing and reducing conditions were about 45 and 28 kDa, respec-
tively. SDS–PAGE likely resulted in multiple broadbands
because miraculin is a glycoprotein. Approximately 1 mg of
puriﬁed recombinant miraculin was obtained from 100 g of
fresh lettuce leaf tissue. This puriﬁcation protocol was repeated
multiple times to obtain a suﬃcient amount of puriﬁed miracu-
lin to test its taste-modifying activity.
3.7. Measurements of the taste-modifying activity
As potential applications for recombinant miraculin
expressed in lettuce may require the use of either a puriﬁed pro-
tein or a less puriﬁed material derived from lettuce leaf tissue, it
is useful to estimate the taste-modifying activity of miraculin
both within a lettuce leaf fraction and as a puriﬁed protein.
To determine whether the miraculin protein within lettuce leaf
tissue possesses taste-modifying activity, lettuce leaf tissue was
used for sensory evaluation. The sweetness induced by 0.02 M
citric acid after chewing 1 or 2 g of transgenic lettuce leaf was
equivalent to that of about 0.2 and 0.3 M sucrose solution
(Table 2), respectively. The sweetness induced by 2 g of trans-
genic lettuce was almost same as that of the sweetness induced
by one miracle fruit, and the sweetening eﬀect did not increase
when more transgenic lettuce was placed in the mouth. No
sweetness was induced under the conditions of this analysis with
non-transgenic lettuce leaf tissue. The evaluation of the taste-
modifying activity of puriﬁed miraculin solutions from miracle
fruit and transgenic lettuce leaf tissues is summarized in Table 2.
The sweetness induced by 0.02 M citric acid after 0.4 lMmira-
culin was held in the mouth was equivalent to the sweetness of
about 0.3 M sucrose solution. This value is equal to that of the
maximum sweetness induced by miraculin [16]. These results
clearly demonstrate that the miraculin expressed in lettuce pos-
sesses strong sweetness-inducing activity.4. Discussion
Plants are increasingly being used as bioreactors for the
commercial production of a number of valuable proteins
[21,22]. The expression of transgenic proteins in edible plants
has the particular advantage of producing materials that can
be consumed directly, a characteristic that has been exploited
to develop oral vaccines [31].
Here, we report the use of a lettuce expression system for the
production of the taste-modifying protein miraculin as a po-
tential alternative sweetener. In the present study, recombinant
miraculin produced in transgenic lettuce plants formed disul-
ﬁde-linked dimer, was N-glycosylated and showed strongsweetness-inducing activity. This suggests that using 35S or
EL2-35S-X promoters, it is possible to produce miraculin in
transgenic plants. In addition, these results imply that the
cleavable N-terminal signal peptide of the precursor of miracu-
lin [14] may regulate folding of the precursor miraculin, induce
translocation, and play a role in secretion of the protein. The
expression levels of miraculin in transgenic lettuce plants were
estimated to be up to 1% of the total soluble protein extracted
from 1 g of fresh tissue, which corresponds to approximately
40 lg of miraculin per gram of lettuce. The sweetness after
exposure to 2 g of transgenic lettuce leaf tissue induced by
0.02 M citric acid was equivalent to that of the sweetness of
0.3 M sucrose. On a molar basis, the sweetness of miraculin
is 300000 times that of sucrose. This suggests that the recom-
binant miraculin expressed in transgenic lettuce is biologically
active and that the expression level is suﬃcient for modifying
taste. Expression of the miraculin protein was detected in T1
and T2 generation transgenic lettuce plants. However, the
expression level of miraculin in the T1 and T2 progenies was
at least 10 times lower than that of T0 plants (data not shown).
Genetic engineering relies on stable integration, the desired le-
vel of expression, and predictable inheritance of the introduced
transgenes, although many recent studies have shown that
transgene instability frequently occurs in transgenic plants
[32,33]. Although the mechanisms of this instability, e.g., gene
silencing or loss, are not fully understood, it is a major obstacle
in the transformation of plants. One of the keys to future suc-
cess will undoubtedly lie in ﬁnding a way to maintain the level
of expression of the recombinant protein in plants over many
generations without silencing. Clearly, there will be a drive to
attain higher levels of expression, and there is much more
room for improvement over established systems. We are also
testing new strategies to increase miraculin production in
transgenic plants. In conclusion, the production of recombi-
nant miraculin in transgenic plants will open up new ways to
study taste-modifying proteins and the commercial application
of miraculin as a low-calorie sweetener.
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